Literature DB >> 23765732

Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.

Daniel P Griese1, Wilko Reents, Anno Diegeler, Sebastian Kerber, Jörg Babin-Ebell.   

Abstract

OBJECTIVES: Aim of this study was to analyze feasibility, efficacy, and safety of a double-ProGlide preclose technique for access site closure after transfemoral transcatheter aortic valve implantation (TAVI).
BACKGROUND: An effective and safe transcutaneous closure device is advantageous in transfemoral TAVI to avoid surgical cut down of the large caliber sheath insertion site. The use of two ProGlide sutures has not been described in this context in a large patient cohort.
METHODS: ProGlide closure was used between 2010 and 2012 in 162 patients. ProGlide sutures were deployed in a preclose technique prior to insertion of the large caliber sheath. Success of the closure technique was defined as effective hemostasis and no further access site-related vascular or bleeding complications during the index hospitalization.
RESULTS: Patients were 82 ± 5 years old with a logistic EuroSCORE of 16.7 ± 12.5. Edwards SAPIEN valves were used in 81.5% and Medtronic CoreValves in 18.5%. The overall success rate of the double-ProGlide technique was 93.9%. Success rate was only 40.0% under circumstances of prolonged high-dose heparinization. Success rate was 96.8% among the patients on dual-antiplatelet therapy (DAPT). All 10 ProGlide failures could effectively be managed by either percutaneous angioplasty or surgical reconstruction. The rate of VARC major vascular complications was 4.3%. Thirty-day mortality was 5.6%.
CONCLUSION: The double-ProGlide preclose technique offers a simple, highly effective, and safe method for closure of the arterial access site after transfemoral TAVI. The double-ProGlide strategy results in low rates of major vascular complications and translates into favorable early outcome.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Perclose ProGlide; transcatheter aortic valve implantation; transfemoral; vascular closure device

Mesh:

Substances:

Year:  2013        PMID: 23765732     DOI: 10.1002/ccd.25053

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  10 in total

Review 1.  Percutaneous management of vascular access in transfemoral transcatheter aortic valve implantation.

Authors:  Ilaria Dato; Francesco Burzotta; Carlo Trani; Filippo Crea; Gian Paolo Ussia
Journal:  World J Cardiol       Date:  2014-08-26

2.  Antithrombotic treatment following transcatheter valve replacement: current considerations.

Authors:  Ioanna Koniari; Nicholas G Kounis; George Hahalis
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance.

Authors:  Amit Kumar; Michael E Matheny; Kalon K L Ho; Robert W Yeh; Thomas C Piemonte; Howard Waldman; Pinak B Shah; Richard Cope; Sharon-Lise T Normand; Sharon Donnelly; Susan Robbins; Frederic S Resnic
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-12-09

4.  Predictors and treatments of Proglide-related complications in percutaneous endovascular aortic repair.

Authors:  Guohua Hu; Bin Chen; Weiguo Fu; Xin Xu; Daqiao Guo; Junhao Jiang; Jue Yang; Yuqi Wang
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

5.  Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device.

Authors:  Zisis Dimitriadis; Werner Scholtz; Stephan M Ensminger; Cornelia Piper; Thomas Bitter; Marcus Wiemer; Marios Vlachojannis; Jochen Börgermann; Lothar Faber; Dieter Horstkotte; Jan Gummert; Smita Scholtz
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

Review 6.  Antithrombotic therapy in TAVI.

Authors:  Manolis Vavuranakis; Konstantinos Kalogeras; Angelos Michail Kolokathis; Dimitrios Vrachatis; Nikolaos Magkoutis; Gerasimos Siasos; Euaggelos Oikonomou; Maria Kariori; Theodoros Papaioannou; Maria Lavda; Carmen Moldovan; Ourania Katsarou; Dimitrios Tousoulis
Journal:  J Geriatr Cardiol       Date:  2018-01       Impact factor: 3.327

7.  Commentary: To slipknot or skip the knot: Preclosure in percutaneous extracorporeal membrane oxygenation cannulation, a misuse of precious time?

Authors:  Gabriel Georges; Siamak Mohammadi
Journal:  JTCVS Tech       Date:  2021-09-24

8.  A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation.

Authors:  Gregor Heitzinger; Christina Brunner; Sophia Koschatko; Varius Dannenberg; Katharina Mascherbauer; Kseniya Halavina; Carolina Doná; Matthias Koschutnik; Georg Spinka; Christian Nitsche; Markus Mach; Martin Andreas; Florian Wolf; Christian Loewe; Christoph Neumayer; Michael Gschwandtner; Andrea Willfort-Ehringer; Max-Paul Winter; Irene M Lang; Philipp E Bartko; Christian Hengstenberg; Georg Goliasch
Journal:  Front Cardiovasc Med       Date:  2022-01-21

9.  Preclosure technique versus arterial cutdown after percutaneous cannulation for venoarterial extracorporeal membrane oxygenation.

Authors:  Abhimanyu Chandel; Mehul Desai; Liam P Ryan; Lindsay Clevenger; Alan M Speir; Ramesh Singh
Journal:  JTCVS Tech       Date:  2021-08-26

10.  Percutaneous Decannulation for Venoarterial Extracorporeal Membrane Oxygenation Using a Perclose ProGlide Closure Device and a Balloon Catheter Without On-Site Cardiac Surgical Backup.

Authors:  Tomohiro Nakamura; Shinya Murata; Ken Tsuboi; Takeshi Ishida; Shin-Ichi Momomura
Journal:  Cureus       Date:  2022-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.